In vivo spectral fluorescence imaging of submillimeter peritoneal cancer implants using a lectin-targeted optical agent

Neoplasia

Volumn 8, Issue 7, 2006, Pages 607-612

  Hama, Yukihiro ^a   Urano, Yasuteru ^b   Koyama, Yoshinori ^a   Kamiya, Mako ^b   Bernardo, Marcelino ^a   Paik, Ronald S ^a   Krishna, Murali C ^a   Choyke, Peter L ^a   Kobayashi, Hisataka ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Metastasis; Microfoci; Optical imaging; Ovarian cancer; Target imaging

Indexed keywords

AVIDIN; FLUORESCEIN; FLUORESCENT DYE; LECTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER SIZE; CANCER TRANSPLANTATION; CONTROLLED STUDY; EX VIVO STUDY; FEMALE; FLUORESCENCE SPECTROSCOPY; IMAGING SYSTEM; IN VIVO STUDY; MOLECULAR IMAGING; MOUSE; NONHUMAN; OPTICAL RESOLUTION; OVARY CANCER; PERITONEUM; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN TARGETING; SENSITIVITY AND SPECIFICITY;

EID: 33745954724     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.06268     Document Type: Article

References (20)

1. Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, and Montz FJ (2002). Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol 20, 1248-1259.
2. Armstrong DK, Bundy B, Wenzel L, Huang HQ, Baergen R, Lele S, Copeland LJ, Walker JL, Burger RA; Gynecologic Oncology Group (2006). Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med 354, 34-43.
3. Yao Z, Zhang M, Sakahara H, Saga T, Arano Y, and Konishi J (1998). Avidin targeting of intraperitoneal tumor xenografts. J Natl Cancer Inst 90, 25-29.
4. Yao Z, Zhang M, Sakahara H, Saga T, Nakamoto Y, Sato N, Zhao S, Arano Y, and Konishi J (1998). Imaging of intraperitoneal tumors with technetium-99m GSA. Ann Nucl Med 12, 115-118.
5. Aalders MC, vd Vange N, Stewart FA, Klein MG, vd Vijver MJ, and Sterenborg HJ (1999). White-light toxicity, resulting from systemically administered 5-aminolevulinic acid, under normal operating conditions. J Photochem Photobiol B 50, 88-93.
6. Bremer C, Ntziachristos V, and Weissleder R (2003). Optical-based molecular imaging: contrast agents and potential medical applications. Eur Radiol 13, 231-243.
7. Ntziachristos V, Bremer C, and Weissleder R (2003). Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging. Eur Radiol 13, 195-208.
8. Ciardella AP, Prall FR, Borodoker N, and Cunningham ET Jr (2004). Imaging techniques for posterior uveitis. Curr Opin Ophthalmol 15, 519-530.
9. Gabius HJ, Engelhardt R, and Cramer F (1986). Endogenous tumor lectins: overview and perspectives. Anticancer Res 6, 573-578.
10. Kobayashi H, Sakahara H, Hosono M, Yao ZS, Toyama S, Endo K, and Konishi J (1994). Improved clearance of radiolabeled biotinylated monoclonal antibody following the infusion of avidin as a "chase" without decreased accumulation in the target tumor. J Nucl Med 35, 1677-1684.
11. Lotan R and Raz A (1988). Lectins in cancer cells. Ann N Y Acad Sci 551, 385-388.
12. Jeong JM, Kinuya S, Paik CH, Saga T, Sood VK, Carrasquillo JA, Neumann RD, and Reynolds JC (1994). Application of high affinity binding concept to radiolabel avidin with Tc-99m labeled biotin and the effect of pI on biodistribution. Nucl Med Biol 21, 935-940.
13. Imai S, Kiyozuka Y, Maeda H, Noda T, and Hosick HL (1990). Establishment and characterization of a human ovarian serous cyst adenocarcinoma cell line that produces the tumor markers CA-125 and tissue polypeptide antigen. Oncology 47, 177-184.
14. Yao Z, Zhang M, Sakahara H, Nakamoto Y, Higashi T, Zhao S, Sato N, Arano Y, and Konishi J (1999). The relationship of glycosylation and isoelectric point with tumor accumulation of avidin. J Nucl Med 40, 479-483.
15. Yogo T, Urano Y, Ishitsuka Y, Maniwa F, and Nagano T (2005). Highly efficient and photostable photosensitizer based on BODIPY chromophore. J Am Chem Soc 127, 12162-12163.
16. Brown SB, Brown EA, andWalker I (2004). The present and future role of photodynamic therapy in cancer treatment. Lancet Oncol 5, 497-508.
17. Scott D, Nitecki DE, Kindler H, and Goodman JW (1984). Immunogenicity of biotinylated hapten-avidin complexes. Mol Immunol 21, 1055-1060.
18. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Feuer EJ, Thun MJ; American Cancer Society (2004). Cancer statistics, 2004. CA Cancer J Clin 54, 8-29.
19. Omura GA, Brady MF, Homesley HD, Yordan E, Major FJ, Buchsbaum HJ, and Park RC (1991). Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience. J Clin Oncol 9, 1138-1150.
20. van Houwelingen JC, ten Bokkel Huinink WW, van der Burg ME, van Oosterom AT, and Neijt JP (1989). Predictability of the survival of patients with advanced ovarian cancer. J Clin Oncol 7, 769-773.